Inhibitors

Inhibitor refers to substance that can hinder the chemical reactions, biological reactions (including immune response) and biological activity. In present time, commonly used inhibitors include immunosuppressants and inhibitors.

1. Immunosuppressive agents: immunosuppressants system refers to drug that can reduce the immune response. It can selectively suppress certain steps of the immune response and immune cells. Immune response refers to the body’s response to a variety of pathogenic substances. Some reactions are favorable to the body and can enhance the body's resistance to disease; some have adverse effects on the body and can cause tissue damage or disorders of physiological functions (allergy). Therefore, patients suffering from allergic reactions being harmful to the body should be subject to the treatment of immunosuppressant to affect the related immune processes and reduce the immune response of the body.

For the treatment of various autoimmune diseases and weakening the tissue incompatibility, it has been developed of a variety of immunosuppressive agents, some of which have been widely used in clinical practice. Commonly used immunosuppressants include glucocorticoids (prednisone, prednisolone, etc.), alkylating agents (nitric oxide mustard, cyclophosphamide, thiotepa, busulfan, etc.), and antimetabolites (6- mercaptopurine, azathioprine, methotrexate, etc.).

The mechanism of immunosuppressants, though not entirely clear, but is characterized by the following several aspects:
① most kinds of immunosuppressants can simultaneously inhibit cellular and humoral immunity and can be used for organ transplantation and autoimmune disease.
②Its inhibitory effect is strong for the primary immune response while the inhibitory effect against secondary response is weak.
③It can simultaneously act on normal and pathological immunity, therefore, can often lead to some complications.
④These drugs often have strong with serious adverse reactions.

2. Enzyme inhibitors: Enzyme inhibitors refer to compounds or drugs being capable of binding to enzyme and inhibit the enzymatic activity. It is clinically often applied of enzyme inhibitors to specially interfere with certain metabolic system to achieve the therapeutic purposes. For example, people use monoamine oxidase inhibitors as antidepressants; use carbonic anhydrase inhibitors as diuretics; use dopa decarboxylase inhibitors as antihypertensive drugs and use antibiotics such as penicillin, cephalosporins belonging to cell wall synthesis inhibitors. Enzyme inhibitors have applications in veterinary medicine and agriculture. In addition, people can also apply enzyme inhibitors to study the mechanism of the enzyme and metabolic pathways.

Enzyme inhibitors often have similar structure with their natural substrates. For designing the inhibitors according modification of natural substrate, people should first analyze and decide the function of each part of the molecule in binding with enzymes: for binding or not binding or repulsion; secondly, people should know the degree of tolerance of the binding site to the adjacent steric hindrance. Then people can replace each functional group to regulate the strength of interaction with the enzyme.

Inhibitors can be divided into reversible and irreversible, two classes. (1)Inhibitors binding with enzyme through non-covalent bonds are called reversible inhibitor. (2)Inhibitors binding to the enzyme via a covalent bond are irreversible inhibitors with strong binding affinity. They will not be affected by concentration change process such as dialysis or dilution after binding to the enzyme.

Click on the specific product, view the latest prices of the products, information, serving information
Structure Chemical Name CAS MF
Galeterone Galeterone 851983-85-2 C26H32N2O
AVP-AEW541 AVP-AEW541 475489-16-8 C27H29N5O
R788(Fostamatinib disodium) R788(Fostamatinib disodium) 1025687-58-4 C23H27FN6NaO9P
Onalespib Onalespib 912999-49-6 C24H31N3O3
4SC-201 4SC-201 864814-88-0 C16H19N3O4S
TAE226 (NVP-TAE226) TAE226 (NVP-TAE226) 761437-28-9 C23H25ClN6O3
CHIR-124 CHIR-124 405168-58-3 C23H22ClN5O
Erteberel (LY500307) Erteberel (LY500307) 533884-09-2 C18H18O3
Tenovin-6 Tenovin-6 1011557-82-6 C25H34N4O2S
ALK/IGF1R inhibitor ALK/IGF1R inhibitor 1356962-20-3 C24H25ClN6O
BMS-265246 BMS-265246 582315-72-8 C18H17F2N3O2
PF-3758309 PF-3758309 898044-15-0 C25H30N8OS
AZD3514 AZD3514 1240299-33-5 C25H32F3N7O2
KPT-185 KPT-185 1333151-73-7 C16H16F3N3O3
WH-4-023 WH-4-023 837422-57-8 C32H36N6O4
Ribociclib Ribociclib 1211441-98-3 C23H30N8O
GLPG0634 GLPG0634 1206101-20-3 C23H18N6O2
Pifithrin-μ Pifithrin-μ 64984-31-2 C8H7NO2S
PJ-34 PJ-34 344458-19-1 C17H17N3O2
ZM 306416 ZM 306416 690206-97-4 C16H13ClFN3O2
Alizapride hydrochloride Alizapride hydrochloride 59338-87-3 C16H22ClN5O2
Dexmedetomidine Dexmedetomidine 113775-47-6 C13H16N2
TPCA-1 TPCA-1 507475-17-4 C12H10FN3O2S
GW0742 GW0742 317318-84-6 C21H17F4NO3S2
3-[(2,4-Dimethylpyrrol-5-yl)methylidenyl]-2-indolinon 3-[(2,4-Dimethylpyrrol-5-yl)methylidenyl]-2-indolinon 194413-58-6 C15H14N2O
SL 327 SL 327 305350-87-2 C16H12F3N3S
5-chloro-3-ethyl-1H-indole-2-carboxylic  acid  [2-(4-piperidin-1-yl-phenyl)-ethyl]-amide 5-chloro-3-ethyl-1H-indole-2-carboxylic acid [2-(4-piperidin-1-yl-phenyl)-ethyl]-amide 868273-06-7 C24H28ClN3O
N-Methyl-N-[2-[[[2-[(2-oxo-2,3-dihydro-1H-indol-5-yl)amino]-5-trifluoromethylpyrimidin-4-yl]amino]methyl]phenyl]methanesulfonamide N-Methyl-N-[2-[[[2-[(2-oxo-2,3-dihydro-1H-indol-5-yl)amino]-5-trifluoromethylpyrimidin-4-yl]amino]methyl]phenyl]methanesulfonamide 717906-29-1 C22H21F3N6O3S
JNJ-26481585 JNJ-26481585 875320-29-9 C21H26N6O2
MK 3207 hydrochloride MK 3207 hydrochloride 957116-20-0 C31H30ClF2N5O3
6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide 6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide 801312-28-7 C27H26N4O5S
5-(2-Oxo-2-phenylethoxy)-3,4-dihydroisoquinolin-1(2H)-one 5-(2-Oxo-2-phenylethoxy)-3,4-dihydroisoquinolin-1(2H)-one 1048371-03-4 C17H13NO3
1-[1-(4-Fluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-(1-pyrrolidinyl)ethanone 1-[1-(4-Fluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-(1-pyrrolidinyl)ethanone 314245-33-5 C18H21FN2O
R406 R406 841290-81-1 C28H29FN6O8S
A66 A66 1166227-08-2 C17H23N5O2S2
6-Amino-8-[(6-iodo-1,3-benzodioxol-5-yl)thio]-N-(1-methylethyl)-9H-purine-9-propanamine 6-Amino-8-[(6-iodo-1,3-benzodioxol-5-yl)thio]-N-(1-methylethyl)-9H-purine-9-propanamine 873436-91-0 C18H21IN6O2S
AMG-208 AMG-208 1002304-34-8 C22H17N5O2
KRN 633 KRN 633 286370-15-8 C20H21ClN4O4
TAK-733 TAK-733 1035555-63-5 C17H15F2IN4O4
R428 R428 1037624-75-1 C30H34N8
GSK 525762A GSK 525762A 1260907-17-2 C22H22ClN5O2
PI3K/HDAC Inhibitor PI3K/HDAC Inhibitor 1339928-25-4 C23H24N8O4S
AGI6780 AGI6780 1432660-47-3 C21H18F3N3O3S2
BMS 833923 BMS 833923 1059734-66-5 C30H27N5O
RKI1447 RKI1447 1342278-01-6 C16H14N4O2S
VS-5584 VS-5584 1246560-33-7 C17H22N8O
iOWH-032 iOWH-032 1191252-49-9 C22H15Br2N3O4
GNF5 GNF5 778277-15-9 C20H17F3N4O3
E-64C E-64C 76684-89-4 C15H26N2O5
(Z,E)-5-(4-ETHYLBENZYLIDINE)-2-THIOXOTHIAZOLIDIN-4-ONE (Z,E)-5-(4-ETHYLBENZYLIDINE)-2-THIOXOTHIAZOLIDIN-4-ONE 403811-55-2 C12H11NOS2
(R,S)-AM1241 (R,S)-AM1241 444912-48-5 C22H22IN3O3
SPLITOMICIN SPLITOMICIN 5690-03-9 C13H10O2
9-(6-Amino-3-pyridinyl)-1-[3-(trifluoromethyl)phenyl]benzo[h]-1,6-naphthyridin-2(1H)-one 9-(6-Amino-3-pyridinyl)-1-[3-(trifluoromethyl)phenyl]benzo[h]-1,6-naphthyridin-2(1H)-one 1223001-51-1 C24H15F3N4O
Torin 1 Torin 1 1222998-36-8 C35H28F3N5O2
CP-724714 CP-724714 537705-08-1 C27H27N5O3
VX-222 VX-222 1026785-59-0 C25H35NO4S
OSI-930 OSI-930 728033-96-3 C22H16F3N3O2S
KU-60019 KU-60019 925701-49-1 C30H33N3O5S
9-Cyclopentyl-2-[[2-methoxy-4-[(1-methylpiperidin-4-yl)oxy]-phenyl]amino]-7-methyl-7,9-dihydro-8H-purin-8-one 9-Cyclopentyl-2-[[2-methoxy-4-[(1-methylpiperidin-4-yl)oxy]-phenyl]amino]-7-methyl-7,9-dihydro-8H-purin-8-one 1124329-14-1 C24H32N6O3
N-(3-Cyano-4,5,6,7-tetrahydrobenzo[b]thienyl-2-yl)-1-naphthalenecarboxamide N-(3-Cyano-4,5,6,7-tetrahydrobenzo[b]thienyl-2-yl)-1-naphthalenecarboxamide 312917-14-9 C20H16N2OS
4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-((1r,4r)-4-hydroxycyclohexylamino)benzamide 4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-((1r,4r)-4-hydroxycyclohexylamino)benzamide 908112-43-6 C23H27F3N4O3
BIX 02189 BIX 02189 1094614-85-3 C27H28N4O2
N-[3-tert-Butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]-N'-[2-fluoro-4-[(2-(methylcarbamoyl)pyridin-4-yl)oxy]phenyl]urea N-[3-tert-Butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]-N'-[2-fluoro-4-[(2-(methylcarbamoyl)pyridin-4-yl)oxy]phenyl]urea 1020172-07-9 C30H28FN7O3
Octanoic acid, 6,8-bis[(phenylMethyl)thio]- Octanoic acid, 6,8-bis[(phenylMethyl)thio]- 95809-78-2 C22H28O2S2
A-674563 A-674563 552325-73-2 C22H22N4O
PF-04929113 PF-04929113 908115-27-5 C25H30F3N5O4
NVP-BGT226 NVP-BGT226 1245537-68-1 C28H25F3N6O2.C4H4O4
BAY 80-6946 (Copanlisib) BAY 80-6946 (Copanlisib) 1032568-63-0 C23H28N8O4
Filgotinib Filgotinib 1206161-97-8 C21H23N5O3S
KGN KGN 4727-31-5 C20H15NO3
PCI 34051 PCI 34051 950762-95-5 C17H16N2O3
BRL 15572 HYDROCHLORIDE BRL 15572 HYDROCHLORIDE 193611-72-2 C25H28Cl2N2O
Oprozomib Oprozomib 935888-69-0 C25H32N4O7S
Skepinone-L Skepinone-L 1221485-83-1 C24H21F2NO4
NVP-BVU 972 NVP-BVU 972 1185763-69-2 C20H16N6
GSK 343 GSK 343 1346704-33-3 C31H39N7O2
TAK-632 TAK-632 1228591-30-7 C27H18F4N4O3S
PURVALANOL A PURVALANOL A 212844-53-6 C19H25ClN6O
S- (+)-Rolipram S- (+)-Rolipram 85416-73-5 C16H21NO3
(-)-MK-801 MALEATE (-)-MK-801 MALEATE 121917-57-5 C20H19NO4
REVERSINE REVERSINE 656820-32-5 C21H27N7O
SCRIPTAID SCRIPTAID 287383-59-9 C18H18N2O4
TG003 TG003 300801-52-9 C13H15NO2S
TYRPHOSTIN AG 1024 TYRPHOSTIN AG 1024 65678-07-1 C14H13BrN2O
LDN-57444 LDN-57444 668467-91-2 C17H11Cl3N2O3
AS 604850 AS 604850 648449-76-7 C11H5F2NO4S
PD153035 HCl PD153035 HCl 183322-45-4 C16H14BrN3O2.HCl
tasquinimod tasquinimod 254964-60-8 C20H17F3N2O4
Ziprasidone Hydrochloride Ziprasidone Hydrochloride 122883-93-6 C21H21ClN4OS
(E)-N-[4-(1-BENZOYL-PIPERIDIN-4-YL)-BUTYL]-3-PYRIDIN-3-YL-ACRYLAMIDE (E)-N-[4-(1-BENZOYL-PIPERIDIN-4-YL)-BUTYL]-3-PYRIDIN-3-YL-ACRYLAMIDE 658084-64-1 C24H29N3O2
2-[[(2E)-3-(2-NAPHTHALENYL)-1-OXO-2-BUTEN-1-YL]AMINO]BENZOIC ACID 2-[[(2E)-3-(2-NAPHTHALENYL)-1-OXO-2-BUTEN-1-YL]AMINO]BENZOIC ACID 321674-73-1 C21H17NO3
GSK461364 GSK461364 929095-18-1 C27H28F3N5O2S
AMG 458 AMG 458 913376-83-7 C30H29N5O5
Aurora A Inhibitor I Aurora A Inhibitor I 1158838-45-9 C31H31ClFN7O2
N-(4-Chloro-3-methoxyphenyl)-2-pyridinecarboxamide N-(4-Chloro-3-methoxyphenyl)-2-pyridinecarboxamide 1161205-04-4 C13H11ClN2O2
5-[[4-(4-Pyridinyl)-6-quinolinyl]methylene]-2,4-thiazolidenedione 5-[[4-(4-Pyridinyl)-6-quinolinyl]methylene]-2,4-thiazolidenedione 958852-01-2 C18H11N3O2S
Wnt-C59 Wnt-C59 1243243-89-1 C25H21N3O
LCL-161 LCL-161 1005342-46-0 C26H33FN4O3S
AZD2461 AZD2461 1174043-16-3 C22H22FN3O3
GNF 5837 GNF 5837 1033769-28-6 C28H21F4N5O2
HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase
Copyright © 2016 ChemicalBook All rights reserved.